Diabetic Retinopathy

• CLINICAL_TRIALS withdrawal · 2024-06-05
  Clinical Trial Update: Unilateral Bevacizumab for Bilateral Diabetic Macular Edema [Phase 4]

  A Phase 4 trial evaluating unilateral bevacizumab for bilateral diabetic macular edema has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2024-05-30
  Clinical Trial Update: Perfluorocarbon Perfused Vitrectomy and 3D Vitrectomy System in Advanced Diabetic Retinopathy [Phase 3]

  A Phase 3 trial evaluating perfluorocarbon perfused vitrectomy and a 3D vitrectomy system for advanced diabetic retinopathy has been withdra…

• CLINICAL_TRIALS withdrawal · 2021-05-05
  Clinical Trial Update: Evaluation of the Retina in Patients With Non-proliferative Diabetic Retinopathy After Aflibercept Injection in the Eye [Phase 4]

  A Phase 4 clinical trial evaluating aflibercept injections for non-proliferative diabetic retinopathy has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2017-05-04
  Clinical Trial Update: Aflibercept for Retinopathy in the Real World

  A real-world trial evaluating aflibercept for diabetic retinopathy (NCT02812030) has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2017-02-23
  Clinical Trial Update: The Role of Prostaglandins in the Progression of Diabetic Retinopathy [Phase 1]

  Phase 1 trial investigating the role of prostaglandins in diabetic retinopathy was withdrawn.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS withdrawal · 2016-06-01
  Clinical Trial Update: Squalamine Lactate Eye Drops in Combination With Ranibizumab in Patients With Diabetic Macular Edema (DME) [Phase 2]

  Phase 2 trial evaluating Squalamine lactate eye drops with ranibizumab for diabetic macular edema has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2015-05-04
  Clinical Trial Update: A Phase 2 Study Exploring The Safety And Efficacy Of Novel Drug Treatment In Subjects With Diabetic Macular Edema (DME) [Phase 2]

  Pfizer-sponsored Phase 2 clinical trial investigating a novel drug for diabetic macular edema has been withdrawn from the study.

• CLINICAL_TRIALS withdrawal · 2014-03-17
  Clinical Trial Update: A Comparison of Islet Cell Transplantation With Medical Therapy for the Treatment of Diabetic Eye Disease [Phase 3]

  A Phase 3 trial comparing islet cell transplantation with medical therapy for diabetic retinopathy and diabetic macular edema has been withd…

• EMA withdrawal · 2007-03-15
  EMA Application withdrawn: Arxxant — Eli Lilly Nederland B.V.

  The EMA withdrew the application for Arxxant by Eli Lilly Nederland B.V. for diabetic retinopathy.